Cyclooxygenase-2 increases hypoxia-inducible factor-1 and vascular endothelial growth factor to promote angiogenesis in gastric carcinoma

Journal of Biomedical Science

Volumn 12, Issue 1, 2005, Pages 229-241

  Huang, Shih Pei ^a   Wu, Ming Shiang ^a   Shun, Chia Tung ^a   Wang, Hsiu Po ^a   Hsieh, Chang Yao ^a   Kuo, Min Liang ^b   Lin, Jaw Town ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Angiogenesis; Cyclooxygenase 2; Gastric carcinoma

Indexed keywords

1 ACETYL 2 (8 CHLORO 10,11 DIHYDRODIBENZ[B,F][1,4]OXAZEPINE 10 CARBONYL)HYDRAZINE; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; DNA; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PROSTAGLANDIN E2; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CELL LINE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIUM CELL; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; STIMULATION; STOMACH CARCINOMA; UMBILICAL VEIN; VASCULARIZATION; VECTORCARDIOGRAPHY; WILD TYPE;

ADULT; AGED; CELL LINE, TUMOR; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; DNA-BINDING PROTEINS; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; NITROBENZENES; NUCLEAR PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; SULFONAMIDES; TRANSCRIPTION FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 17744386137     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1007/s11373-004-8177-5     Document Type: Article

References (46)

1. D. Hanahan R.A. Weinberg 2000 The hallmarks of cancer Cell 100 57 70
2. L.M. Coussens Z. Werb 2002 Inflammation and cancer Nature 420 860 867
3. P.A. Janne R.J. Mayer 2000 Chemoprevention of colorectal cancer New Engl. J. Med. 342 1960 1968
4. G.A. FitzGerald C. Patrono 2001 The coxibs, selective inhibitors of cyclooxygenase-2 New Engl. J. Med. 345 433 442
5. P. Carmeliet R.K. Jain 2000 Angiogenesis in cancer and other diseases Nature 407 249 257
6. J. Folkman 1995 Seminars in Medicine of the Beth Israel Hospital, Boston Clinical applications of research on angiogenesis. New Engl. J. Med. 333 1757 1763
7. N. Ferrara H.P. Gerber J. LeCouter 2003 The biology of VEGF and its receptors Nat. Med. 9 669 676
8. P. Carmeliet Y. Dor J.M. Herbert D. Fukumura K. Brusselmans M. Dewerchin M. Neeman F. Bono R. Abramovitch P. Maxwell C.J. Koch P. Ratcliffe L. Moons R.K. Jain D. Collen E. Keshert E. Keshet 1998 Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis Nature 394 485 490
9. A. Giaccia B.G. Siim R.S. Johnson 2003 HIF-1 as a target for drug development Nat. Rev. Drug Discov. 2 803 811
10. G.L. Semenza 2003 Targeting HIF-1 for cancer therapy Nat. Rev. Cancer 3 721 732
11. J.W. Lee S.H. Bae J.W. Jeong S.H. Kim K.W. Kim 2004 Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions Exp. Mol. Med. 36 1 12
12. K. Subbaramaiah A.J. Dannenberg 2003 Cyclooxygenase 2: a molecular target for cancer prevention and treatment Trends Pharmacol. Sci. 24 96 102
13. K. Saukkonen J. Rintahaka A. Sivula C.J. Van Buskens B.P. Rees M.C. Rio C. Van Haglund J.J. Lanschot G.J. Offerhaus A. Ristimaki 2003 Cyclooxygenase-2 and gastric carcinogenesis Apmis. 111 915 925
14. P.J. Hu J. Yu Z.R. Zeng W.K. Leung H.L. Lin B.D. Tang A.H. Bai J.J. Sung 2004 Chemoprevention of gastric cancer by celecoxib in rats Gut 53 195 200
15. A.J. Dannenberg N.K. Altorki J.O. Boyle C. Dang L.R. Howe B.B. Weksler K. Subbaramaiah 2001 Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer Lancet Oncol. 2 544 551
16. M.A. Iniguez A. Rodriguez O.V. Volpert M. Fresno J.M. Redondo 2003 Cyclooxygenase-2: a therapeutic target in angiogenesis Trends Mol. Med. 9 73 78
17. T. Kajitani 1981 The general rules for the gastric cancer study in surgery and pathology Part I. Clinical classification. Jpn. J. Surg. 11 127 139
18. D.R. Lauren D.J. Jensen J.A. Douglas J.M. Follett 2001 Efficient method for determining the glycyrrhizin content of fresh and dried roots, and root extracts, of Glycyrrhiza species Phytochem. Anal. 12 332 335
19. K.S. Chapple E.J. Cartwright G. Hawcroft A. Tisbury C. Bonifer N. Scott A.C. Windsor P.J. Guillou A.F. Markham P.L. Coletta M.A. Hull 2000 Localization of cyclooxygenase-2 in human sporadic colorectal adenomas Am. J. Pathol. 156 545 553
20. R. Yamaguchi H. Yano A. Iemura S. Ogasawara M. Haramaki M. Kojiro 1998 Expression of vascular endothelial growth factor in human hepatocellular carcinoma Hepatology 28 68 77
21. S.P. Huang M.S. Wu C.T. Shun H.P. Wang J.T. Lin 2002 Tumor angiogenesis increases with nuclear p53 accumulation in gastric carcinoma Hepatogastroenterology 49 1453 1456
22. M.J. Fackler C.I. Civin D.R. Sutherland M.A. Baker W.S. May 1990 Activated protein kinase C directly phosphorylates the CD34 antigen on hematopoietic cells J. Biol. Chem. 265 11056 11061
23. Y. Kubota H.K. Kleinman G.R. Martin T.J. Lawley 1988 Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures J. Cell. Biol. 107 1589 1598
24. J.C. Juarez X. Guan N.V. Shipulina M.L. Plunkett G.C. Parry D.E. Shaw J.C. Zhang S.A. Rabbani K.R. McCrae A.P. Mazar W.T. Morgan F. Donate 2002 Histidine-proline-rich glycoprotein has potent antiangiogenic activity mediated through the histidine-proline-rich domain Cancer Res. 62 5344 5350
25. K.M. Comerford T.J. Wallace J. Karhausen N.A. Louis M.C. Montalto S.P. Colgan 2002 Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene Cancer Res. 62 3387 3394
26. I. Caniggia H. Mostachfi J. Winter M. Gassmann S.J. Lye M. Kuliszewski M. Post 2000 Hypoxia-inducible factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGFbeta(3) J. Clin. Invest. 105 577 587
27. Y.E. Joo J.S. Rew Y.H. Seo S.K. Choi Y.J. Kim C.S. Park S.J. Kim 2003 Cyclooxygenase-2 overexpression correlates with vascular endothelial growth factor expression and tumor angiogenesis in gastric cancer J. Clin. Gastroenterol. 37 28 33
28. W.K. Leung K.F. To M.Y. Go K.K. Chan F.K. Chan E.K. Ng S.C. Chung J.J. Sung 2003 Cyclooxygenase-2 upregulates vascular endothelial growth factor expression and angiogenesis in human gastric carcinoma Int. J. Oncol. 23 1317 1322
29. H.X. Li X.M. Chang Z.J. Song S.X. He 2003 Correlation between expression of cyclooxygenase-2 and angiogenesis in human gastric adenocarcinoma World J. Gastroenterol. 9 674 677
30. H.G. Yu J.Y. Li Y.N. Yang H.S. Luo J.P. Yu J.J. Meier H. Schrader A. Bastian W.E. Schmidt F. Schmitz 2003 Increased abundance of cyclooxygenase-2 correlates with vascular endothelial growth factor-A abundance and tumor angiogenesis in gastric cancer Cancer Lett. 195 43 51
31. P.J. Keck S.D. Hauser G. Krivi K. Sanzo T. Warren J. Feder D.T. Connolly 1989 Vascular permeability factor, an endothelial cell mitogen related to PDGF Science 246 1309 1312
32. D.W. Leung G. Cachianes W.J. Kuang D.V. Goeddel N. Ferrara 1989 Vascular endothelial growth factor is a secreted angiogenic mitogen Science 246 1306 1309
33. P.H. Maxwell P.J. Ratcliffe 2002 Oxygen sensors and angiogenesis Semin. Cell Dev. Biol. 13 29 37
34. G.L. Semenza 2002 HIF-1 and tumor progression: pathophysiology and therapeutics Trends Mol. Med. 8 S62 67
35. Y.S. Chun M.S. Kim J.W. Park 2002 Oxygen-dependent and -independent regulation of HIF-1alpha J. Korean Med. Sci. 17 581 588
36. M.K. Jones I.L. Szabo H. Kawanaka S.S. Husain A.S. Tarnawski 2002 von Hippel Lindau tumor suppressor and HIF-1alpha: new targets of NSAIDs inhibition of hypoxia-induced angiogenesis Faseb J. 16 264 266
37. N. Futaki S. Takahashi M. Yokoyama I. Arai S. Higuchi S. Otomo 1994 NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro Prostaglandins 47 55 59
38. N. Futaki I. Arai Y. Hamasaka S. Takahashi S. Higuchi S. Otomo 1993 Selective inhibition of NS-398 on prostanoid production in inflamed tissue in rat carrageenan-air-pouch inflammation J. Pharm. Pharmacol. 45 753 755
39. S.T. Palayoor P.J. Tofilon C.N. Coleman 2003 Ibuprofen-mediated reduction of hypoxia-inducible factors HIF-1alpha and HIF-2alpha in prostate cancer cells Clin. Cancer Res. 9 3150 3157
40. A. Rapisarda B. Uranchimeg D.A. Scudiero M. Selby E.A. Sausville R.H. Shoemaker G. Melillo 2002 Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway Cancer Res. 62 4316 4324
41. Y.J. Jung J.S. Isaacs S. Lee J. Trepel L. Neckers 2003 IL-1beta-mediated up-regulation of HIF-1alpha via an NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis Faseb J. 17 2115 2117
42. W.J. Lukiw A. Ottlecz G. Lambrou M. Grueninger J. Finley H.W. Thompson N.G. Bazan 2003 Coordinate activation of HIF-1 and NF-kappaB DNA binding and COX-2 and VEGF expression in retinal cells by hypoxia Invest. Ophthalmol. Vis. Sci. 44 4163 4170
43. Y.Q. Wang J.M. Luk K. Ikeda K. Man A.C. Chu K. Kaneda S.T. Fan 2004 Regulatory role of vHL/HIF-1alpha in hypoxia-induced VEGF production in hepatic stellate cells Biochem. Biophys. Res. Commun. 317 358 362
44. M.J. Thun S.J. Henley C. Patrono 2002 Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues J. Natl. Cancer Inst. 94 252 266
45. B.S. Reddy H. Maruyama G. Kelloff 1987 Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal antiinflammatory drug, during different stages of rat colon tumor development Cancer Res. 47 5340 5346
46. S.P. Huang M.S. Wu C.T. Shun H.P. Wang M.T. Lin M.L. Kuo J.T. Lin 2004 Interleukin-6 increases vascular endothelial growth factor and angiogenesis in gastric carcinoma J. Biomed. Sci. 11 517 527